Please login to the form below

Not currently logged in
Email:
Password:

Agneta Svedberg appointed COO at Zealand Pharma

Succeeds company co-founder John Hottel who retires

Agneta Svedberg, Zealand PharmaZealand Pharma has picked Agneta Svedberg to succeed John Hottel as senior VP and chief operating officer.

Hottel is retiring after 15 years at the Denmark-based company he co-founded in 1998.

His successor Svedberg, who takes up her new role from February 1, 2013, joins the firm from Swedish biotech Cantargia where she served as CEO.

The appointment comes at crucial time for Zealand, with its diabetes partnership with Sanofi set to pay off as the big pharma company gears up to launch Lyxumia (lixisenatide) this year.

Svedberg has more than 20 years of experience in the industry, most of which has been spent in northern Europe and includes a ten-year spell with Genmab in Denmark, where her most senior role was global head of clinical development.

She also spent time as head of clinical development (Europe) at Oxigene Europe.

“Our company now stands on the threshold of a new level of maturity and growth,” said Zealand's president and CEO David Solomon, “and we are confident that Agneta holds the right competences to help structure and steer our organisation optimally to support this transition, both on a strategic and operational level."

Solomon also paid tribute to the departing Hottel, commenting: “John has been instrumental in the successful development of Zealand Pharma's business and organisation since the company's inception, and the Board and I thank him for his valuable contribution and wish him the very best upon his retirement.”

7th January 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

WHITE PAPER: The increasing importance of clinical trial marketing advertising in patient recruitment
Learn why advertising is more important than ever in clinical studies...
The 'winner takes all' pricing game
Tendering has long been common in healthcare for medical devices and diagnostics; the Gulf Cooperation Council and the Jamaica Commodity Trading Company have been using pharmaceutical tendering since the 1970s....
Early diagnosis underpins NHS cancer strategy
Paul Midgley, Oli Hudson and Sarah Shield, of Wilmington Healthcare, explore how the NHS is tackling cancer in line with the Long-term Plan...

Infographics